It's been in so many announcements. Here's 3 for starters:
9/5/25: 12 Distributors signed... Orthocell CEO and MD, Paul Anderson, said: “It’s very pleasing to see such rapid progress on the expansionof our US distributor network so soon after receiving US FDA clearance in April. We’re well ahead of thetargets we had set ourselves and expect that to translate to first US Remplir sales this quarter."
14/4/25: Quarterly Report – March 2025 "Orthocell is well placed to generate first US sales this financial year "
4/4/25: Investor Presentation US first sales 2Q CY25
OCC Price at posting:
$1.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)